The Westin Tokyo
1 Chome-4-1 Mita, Meguro
Tokyo, Japan 153-8580
The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates, and network with potential collaborators. This event is scheduled for Friday, October 11, from 10:00AM to 5:00PM, followed by networking cocktail hour. Breakfast and a box lunch will be provided to attendees.
The purpose of this seminar is to bridge the gap between protein drug development and recent academic research on Tregs, Tregitopes, with a special focus on immunogenicity, deimmunization, and tolerance induction.
Discussion topics are to include:
- Determinants of immunogenicity
- Induction of tolerance
- Measuring and modulating immunogenicity
- Immunogenicity and tolerance in immuno-oncology applications
Featured keynote speakers are to include:
Annie De Groot, MD
Research Professor and Director, Institute for Immunology and Informatics (iCubed)
“Setting the Stage: Immunogenicity and Tolerance“
Brandon DeKosky, PhD
Assistant Professor, Departments of Pharmaceutical Chemistry and Chemical Engineering, The University of Kansas
“NGS-Based Analyses of Antibody Function and Protein Immunogenicity“
Ken j. Ishii, M.D., PhD
Professor, Division of Vaccine Science
Director, International Research and Development Center for Mucosal Vaccines
Institute for Medical Science, University of Tokyo
“Innate Immunity as Adjuvant: Pathway to Immunogenicity for Cancer Vaccines and ‘Adverse’ Immune responses to Biologics“
Takuya Tsunoda, M.D., PhD
Chief Professor, Department of Medical Oncology
Showa University School of Medicine
“Have ICIs opened Pandora’s Box? Pros & Cons of Therapeutic Benefit“
Kiyoshi Yoshimura, M.D., PhD
Professor, Department of Immuno-Oncology
Talk title to be announced
* KEEP CHECKING BACK FOR UPDATES! *
Interested in attending our seminar? Register here!
In the meantime, check out our previous Westin Immunogenicity Seminars!